Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT00059891What this trial is testingAnal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal CancerWho this might be right forAnal CancerColorectal CancerPerioperative/Postoperative Complications Memorial Sloan Kettering Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT00025090What this trial is testingRadiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal CancerWho this might be right forAnal Cancer University College London (UCL) Cancer Institute 600
Large-scale testing (Phase 3)Study completedNCT00003652What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer UNICANCER 350
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00316888What this trial is testingCetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal CancerWho this might be right forAnal Cancer ECOG-ACRIN Cancer Research Group 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT04929028What this trial is testingTherapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerWho this might be right forAIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell Carcinoma+7 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04166318What this trial is testingLower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE StudyWho this might be right forAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Canal Squamous Cell Carcinoma+3 more ECOG-ACRIN Cancer Research Group 252
Large-scale testing (Phase 3)Study completedNCT00003596What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer Radiation Therapy Oncology Group 682
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Ended earlyNCT00068744What this trial is testingRadiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal CancerWho this might be right forAnal Cancer European Organisation for Research and Treatment of Cancer - EORTC 88
Testing effectiveness (Phase 2)Study completedNCT00423293What this trial is testingIntensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal CancerWho this might be right forAnal Cancer Radiation Therapy Oncology Group 63
Not applicableLooking for participantsNCT07112690What this trial is testingGanglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer TreatmentWho this might be right forLocalized Anal CarcinomaLocalized Anal Margin CarcinomaStage 0 Anal Cancer AJCC v8+3 more Emory University 5
Large-scale testing (Phase 3)Active Not RecruitingNCT03233711What this trial is testingNivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerWho this might be right forAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell Carcinoma+2 more National Cancer Institute (NCI) 344
Not applicableStudy completedNCT05130073What this trial is testing4-Point Therapy Response Score With PET/CT for Anal Squamous Cell CancerWho this might be right forAnal Squamous Cell CarcinomaStage 0 Anal Cancer AJCC v8Stage I Anal Cancer AJCC v8+7 more M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT00955240What this trial is testingRadiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal CancerWho this might be right forAnal Cancer UNICANCER 16
Not applicableLooking for participantsNCT04221893What this trial is testingRadiation Therapy for the Treatment of Metastatic Gastrointestinal CancersWho this might be right forStage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more University of California, San Francisco 28
Not applicableEnded earlyNCT02140021What this trial is testingBiospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and CancerWho this might be right forCervical AdenocarcinomaCervical Adenocarcinoma In SituCervical Intraepithelial Neoplasia+52 more M.D. Anderson Cancer Center 409
Testing effectiveness (Phase 2)Study completedNCT00324415What this trial is testingCombined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal CancerWho this might be right forAnal Cancer AIDS Malignancy Consortium 45
Testing effectiveness (Phase 2)Study completedNCT03690921What this trial is testingLinear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility TrialWho this might be right forAnal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8+6 more M.D. Anderson Cancer Center 8